Una investigación reciente ha permitido desentrañar qué le ocurrió exactamente a Ganimedes hace cuatro mil millones de años. Ganimedes, uno de los satélites del planeta Júpiter, es la luna más grande de nuestro sistema solar. Es m&aacu …
La catástrofe que sufrió la luna más grande del sistema solar Read More »
El Síndrome de Piernas Inquietas (SPI), también conocido como enfermedad de Willis-Ekbom, es un trastorno neurológico que afecta a millones de personas en todo el mundo. Se caracteriza por una necesidad irresistible de mover las piernas, acompañada de sensaciones inc&oacu …
Los antibióticos son el eje de la medicina moderna: sin ellos, cualquier persona con heridas abiertas o que deba someterse a una intervención quirúrgica correría un riesgo constante de contraer infecciones peligrosas. Por desgracia, la humanidad se enfrenta a una crisis g …
Posibles nuevos antibióticos provenientes de microbios marinos árticos Read More »
Chief financial officer Mark Keim is taking the reins of the health insurer’s bread-and-butter business — Medicaid — along with a growing marketplace division.
Molina puts CFO in charge of Medicaid, ACA marketplace businesses Read More »
After years of struggles, Rite Aid filed for bankruptcy last October and in the ensuing months worked to close hundreds of stores.
The European Society of Cardiology said the treatment may be considered for certain patients with uncontrolled, drug-resistant high blood pressure but outlined lingering concerns.
European heart group recommends renal denervation for some patients Read More »
AI was the most compelling new technology for the fourth year in a row, with leaders also saying the technology had shown the most improvement,according to the Center for Connected Medicine.
AI still the most exciting emerging technology for healthcare: survey Read More »
ImmunityBio will lay off 16 employees in El Segundo, California, and said it expects to need more funding to commercialize Anktiva, approved in April for non-muscle invasive bladder cancer.
ImmunityBio to Lay Off 16, Will Likely Need Additional Capital Read More »
Under a multi-year agreement announced Wednesday, Eli Lilly will leverage Haya Therapeutics’ proprietary RNA-guided genome platform to identify drug targets to address the chronic conditions.
Proceeds from the oversubscribed financing will be used to advance ArsenalBio’s lead programs, which include a handful of solid tumor cell therapy candidates.
ArsenalBio Snags Mega $325M Series C Round With Backing from Nvidia, Regeneron Read More »
